ABSI — Absci

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It en...

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Industry

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Sector

Healthcare

Exchange

NASD

First trade date

2021-07-22

The interactive platform loads with JavaScript. Research tools are for informational purposes.